SCHEMBL7013304

SCHEMBL7013304

CC(C(=O)OCc1ccccc1)[C@@H]1NC(=O)OC1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
IDO1 P14902 2/20 0.41
NAAA Q02083 2/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ATM Q13315 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTR2C P28335 1/20 0.39
ADORA2B P29275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323988 0.84 IDO1 (0.46) ALDH1A1IDO1CYP3A4CYP2C9CYP2C19
SCHEMBL24569731 0.80 CTSD (0.40) ALDH1A1MAPTCYP3A4CYP2C9CYP2C19
SCHEMBL24569694 0.80 CTSD (0.40) ALDH1A1MAPTCYP3A4CYP2C9CYP2C19
SCHEMBL14299552 0.77 CTSK (0.46) IDO1ATM
SCHEMBL16088872 0.75 HTR2C (0.43) ALDH1A1IDO1MAPTHPGDHSD17B10
SCHEMBL20669714 0.74 ALDH1A1 (0.45) ALDH1A1IDO1NAAAMAPTHPGD
SCHEMBL4413019 0.73 GLA (0.55) ALDH1A1MAPK1L3MBTL1SLC6A2SLC6A3
SCHEMBL9886347 0.73 GLA (0.55) ALDH1A1MAPK1L3MBTL1SLC6A2SLC6A3
SCHEMBL9917628 0.73 GLA (0.55) ALDH1A1MAPK1L3MBTL1SLC6A2SLC6A3
SCHEMBL21522839 0.72 CYP1A2 (0.42) ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670447-B2 An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example MITSUI CHEMICALS, INC. (JP) 2003-12-30 US disclosed
EP-1298127-A1 AMINO ACID-N-CARBOXY ANHYDRIDES HVAING SUBSTITUENT AT NITROGEN Mitsui Chemicals, Inc. (JP) 2003-04-02 EP disclosed
US-20020173664-A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen MITSUI CHEMICALS, INC. (JP) 2002-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173664-A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen DNPEP, HDGF, ANPEP ALDH1A1 702/4885IDO1 562/4885NAAA 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.